drugset
drugset / Trial / NCT06263881

Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia

NCT06263881 ↗

Phase 3 Completed 370 enrolled Materia Medica Holding
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Multicenter double-blind placebo-controlled randomized in parallel groups clinical trial.

Timeline

Start
2023-12-01
Primary completion
2025-03-19
Completion
2025-03-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Raphamin Unknown 1 unknown Oral

Indications

pneumonia